An interventional study of Voice therapy: respiratory and Voice therapy: glottal closure in Presbylarynx and Age-Related Dysphonia, sponsored by University of Arizona. Active, not recruiting at 2 sites in United States. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-10.
Sponsored by University of Arizona · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 71 studies in Dysphonia with a site in United States — 20 open to participants now, 21 under way, 1 of them phase 3. Dysphonia · United States.
Among the 71 studies in Dysphonia with a site in United States, this one is the 3rd largest by planned enrollment of the 53 interventional ones that give a count, is one of 2 that started in 2019, is one of 31 with no phase, reaches primary completion later than 1 of the 20 other live ones, and was the 32nd registered.
132 studies on the registry are indexed under Dysphonia; 38 are open to participants now.
Browse Dysphonia studies →20 of the 71 studies in Dysphonia with a site in United States are open now. Recruiting first, the newest first:
Massachusetts General Hospital · Sites in United States
Ages 14+
University of Minnesota · Sites in United States
Ages 18–75 · Healthy volunteers
Emory University · Sites in United States
Ages 16–65
University of California, San Diego · Sites in United States
Ages 18–89
Yale University · Sites in United States
Ages 18–65
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 25 Dysphonia studies recruiting now, 8 (32%) set no upper age limit and 9 (36%) stop at 75 or younger; 7 take children under 18; 14 take healthy volunteers.
This study: 65 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
71 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 9 · Phase 2 11 · Phase 3 4 · Phase 4 5
First in 1992; this study’s year is marked. 2 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 220 is above the median of 30 across 87 interventional studies indexed under Dysphonia.
Median enrollment 32 across the 53 interventional studies, 170 across the 18 observational. Of the 41 that completed or were terminated, 17 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 71 have an industry lead sponsor. The 10 most frequent:
University of Arizona is the lead sponsor of 477 studies on the registry; 88 are open to participants now.
Of its 51 completed or terminated interventional studies of FDA-regulated products, 30 (59%) have results posted.
University of Arizona has 1 study filed under Dysphonia — fewer than ten, so there is no comparison to draw.
12 of the studies in Dysphonia with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07145086Phase 3Texas Christian UniversityTranslaryngeal Vibration for Hyperfunctional Voice Disorders | 2027-04-30 |
| NCT06830174Yale UniversitytDCS for Laryngeal Dystonia | 2026-12 |
| NCT03702322University of ArizonaImproving Voice Production for Adults With Age-related Dysphonia | 2026-12-30 |
| NCT05095740MGH Institute of Health ProfessionsEffects of Neuromodulation in Laryngeal Dystonia | 2026-12-31 |
| NCT07443891University of MinnesotaBrain Network Changes After Vibro-tactile Stimulation in Laryngeal Dystonia | 2027-02-28 |
Add all 12 to your calendar (.ics) → With an account.
Among the 71 studies in Dysphonia with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The objectives for this research are to determine the mechanisms by which specific therapy tasks improve voice in age-related dysphonia, and the conditions that limit the extent of improvement. The central hypothesis is that targeted therapy tasks will improve voice, and that severity will determine the extent of improvement.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All participants will undergo each treatment.
Behavioral: Voice therapy: respiratory · Behavioral: Voice therapy: glottal closure · Behavioral: Voice therapy: loud · Behavioral: Voice therapy: Semiocclusion
Abdominal voice onset
Pulling/pushing task
Assertive task
Semi-occluded vocal tract
Relative glottal gap from laryngeal high-speed videoendoscopy
Time frame: End of year 3
Perceived voice quality
Participants will score the construct of "overall voice quality" using a technique called "sort and rate" in which listeners move icons representing each sound along a line. They align the icons so that best voices are on one side and worst voices are on the other. The distance between the icons represents how much better or worse one sound is than the other. There are no units to the scale. Rankings from all listeners are combined using the statistical technique of multidimensional scaling. The result is a ranked value for each sound file (i.e., voice production) that shows how different they are. There is no highest or lowest value.
Time frame: End of year 3
Acoustic measure of voice quality (Cepstral Peak Prominence)
Time frame: End of year 3
Open quotient from laryngeal high-speed videoendoscopy
Time frame: End of year 3
Speed index from laryngeal high-speed videoendoscopy
Time frame: End of year 3
Maximum area declination ratefrom laryngeal high-speed videoendoscopy
Time frame: End of year 3
Fundamental frequency standard deviation from laryngeal high-speed videoendoscopy
Time frame: End of year 3
Started Apr 2019 (actual). Primary completion is estimated for Dec 2026, 92 months after the start.
Of 44 non-industry interventional studies with no phase under Dysphonia, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 47. This study's planned 92 months is above that.
Counting every sponsor, half of 44 studies reached it within 26 months; a quarter within 11 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.